Nike Mag auction raises nearly $7m for Parkinson’s cure research

Global update

Author: Parkinson's Life editorsPublished: 21 October 2016

Prep: Cook: Serves:

Michael J Fox applauds Nike as it raises million for his Foundation by auctioning pairs of the Nike Mag trainers with iconic ‘power laces’

Nike has raised US$6.75 million for the Michael J Fox Foundation (MJFF) after auctioning 88 pairs of the self-lacing ‘Mag’ trainers – as worn by Fox in the classic 1989 film ‘Back to the Future II’.

Trainer aficionados worldwide were invited to take part in an online draw for the chance to win a pair. They made donations of $10 per entry to the Foundation, which promised that all proceeds “will go straight to speeding a cure for Parkinson’s disease”.

Thanks to an anonymous donor, donations in the last 12 hours of the draw were doubled and matched dollar for dollar. The winners of the limited-edition sneakers were announced on October 17. The 89th pair of Nike Mags will be auctioned to the highest bidder at the Foundation’s benefit gala on November 12 in New York City.

A similar event took place in 2011, when Nike held a 10-day eBay auction of 1,500 pairs of Nike Mag sneakers. In total, the company has now raised more than $16 million for the Foundation.

Michael J Fox said: “Thanks to Nike, we’ve raised a boatload of money for research and we’ve had tons of fun while doing it. We’re grateful to everyone who’s engaged in our work and we welcome those who have come to learn more about us through this amazing partnership.”

Nike Mag

Last Month

Next Month

Go Back

Share this story

Comments

Global update

#UniteForParkinsons: the story so far

Highlights from #UniteForParkinsons 2017

World Parkinson Congress 2019 Bloggers: Allison Smith

#WPC2019: We talk to US blogger Allison Smith

Michael J Fox Foundation CEO hails advances in Parkinson’s treatment

The MJFF’s Todd Sherer discusses advances in Parkinson’s

Plant-based compounds could treat chronic pain in Parkinson’s, study finds

A six-year study has found that chronic pain in people with Parkinson’s is linked to a gene involved with how the brain responds to cannabis compounds. The investigation examined why some people with the condition experience persistent pain – and the impact it has on their work, daily life and social relationships. Conducted by researchers at Manchester’s Salford Royal Foundation Trust, UK, and funded by Parkinson’s UK, it is the largest study to investigate chronic pain in people with Parkinson’s. Dr Monty Silverdale, consultant neurologist at Greater Manchester Centre, said: “This study is significant because it shows the important role of genetics in chronic pain in Parkinson’s. “Our findings suggest that cannabis-based compounds may be worth investigating as a treatment for pain in Parkinson’s.”

Could playing table tennis help reduce Parkinson’s symptoms?

Researchers at Fukuoka University, Japan, have found that playing table tennis may help alleviate motor symptoms in Parkinson’s. As part of the study, 12 people with Parkinson’s with an average age of 73 played a five-hour session of table tennis every week for a period of six months. The sessions were developed specifically for people with the condition by experienced table tennis players from the university’s department of sports science. The participants were evaluated after three months and at the end of the study. At both evaluations, participants had reduced symptoms – showing improvement in speech, handwriting, walking and hand tremors. Two participants reported side-effects of backache and falling. Study author Ken-ichi Inoue, MD, of Fukuoka University said: “While this study is small, the results are encouraging because they show ping pong, a relatively inexpensive form of therapy, may improve some symptoms of Parkinson’s disease. A much larger study is…

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Researchers have discovered that a molecule called BT13 could have potential to treat Parkinson’s. The study, conducted by scientists from the University of Helsinki, Finland, found that mice injected with the BT13 molecule had an increase in dopamine levels in the brain. Their findings also suggested that the molecule could lead to a new drug treatment to protect the brain cells that produce dopamine. Dopamine helps coordinate movement, but people with Parkinson’s have normally lost between 70 and 80% of the brain cells that produce the neurotransmitter when they are diagnosed with the condition. Professor David Dexter, Deputy Director of Research at Parkinson’s UK – which co-funded the study – said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms. “More research is needed to turn BT13 into a treatment to be tested in clinical trials, to…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Nike Mag auction raises nearly $7m for Parkinson’s cure research

Global update

Author: Parkinson's Life editorsPublished: 21 October 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Global update

#UniteForParkinsons: the story so far

Interviews

World Parkinson Congress 2019 Bloggers: Allison Smith

Perspectives

Michael J Fox Foundation CEO hails advances in Parkinson’s treatment

Plant-based compounds could treat chronic pain in Parkinson’s, study finds

Could playing table tennis help reduce Parkinson’s symptoms?

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

{title}

Subscribe

Nike Mag auction raises nearly $7m for Parkinson’s cure research

Global update

Author: Parkinson's Life editorsPublished: 21 October 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Global update

#UniteForParkinsons: the story so far

Interviews

World Parkinson Congress 2019 Bloggers: Allison Smith

Perspectives

Michael J Fox Foundation CEO hails advances in Parkinson’s treatment

Plant-based compounds could treat chronic pain in Parkinson’s, study finds

Could playing table tennis help reduce Parkinson’s symptoms?

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

{title}

Subscribe

Sign in